Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Clinical trial NCT05316155 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05316155
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2028-03-30
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.